Tag: investing in Numinus Wellness Inc.
Numinus and MAPS Public Benefit Corporation announce collaboration agreement to seek approval of MDMA-assisted psychotherapy for PTSD single-arm, open-label trial
Numinus Announces Compassionate Access Trial of Psilocybin-Assisted Psychotherapy for Substance Use Disorders
Numinus Appoints Multidisciplinary Global Leaders to its General Advisory Council
